Indian journal of psychiatry · 2025
Unpacking medication choices: Key factors influencing treatment decisions in children with newly diagnosed attention deficit hyperactivity disorder.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chauhan Nidhi, Venkatesan Velprashanth, Sharma Akhilesh, Shah Ruchita, Grover Sandeep, Basu Debashish
Аннотация
BACKGROUND: Following a diagnosis of Attention-deficit/hyperactivity disorder (ADHD) many children require immediate use of pharmacological agents for symptom control, while for some children a trial of non-pharmacological management may be warranted initially.
AIM: To study and identify the clinical and socio-economic factors associated with immediate use of pharmacotherapy versus non pharmacological management in children with newly diagnosed ADHD.
METHODS: A retrospective cross sectional study design using chart review was conducted in child and adolescent psychiatry services of a tertiary care hospital. The medical records between 2018 and 2020 were reviewed. The socio-demographic factors, symptom profiles and comorbidities were recorded. Descriptive statistics and Binary Logistic regression analyses were calculated for factors associated with use versus non-use of pharmacotherapy.
RESULTS: 187 patients screened positive for ADHD at the walk-in clinic and after detailed assessments, 101 were diagnosed with ADHD. With every one-point increase in Vanderbilt ADHD Parent Rating Scale (VADPRS) severity score, there is 1.2 times [P = 0.002; Exp(B) = 1.281; 99% CI: 1.089-1.494] higher likelihood of getting a pharmacological prescription for ADHD. Combined presentation has 3.8 times [P = 0.015; Exp(B) = 3.808; 99% CI: 1.295-11.198] higher likelihood of getting a pharmacological prescription compared to only hyperactive/impulsive and inattentive presentations. Among the socio-demographic variables, no statistically significant variables were observed, although the odds ratios among all social categories displayed a meaningful trend.
CONCLUSION: Pharmacotherapy for ADHD at initial diagnosis is strongly predicted by the severity of ADHD and other socio-economic variable that may require equal attention in the coming years.
AIM: To study and identify the clinical and socio-economic factors associated with immediate use of pharmacotherapy versus non pharmacological management in children with newly diagnosed ADHD.
METHODS: A retrospective cross sectional study design using chart review was conducted in child and adolescent psychiatry services of a tertiary care hospital. The medical records between 2018 and 2020 were reviewed. The socio-demographic factors, symptom profiles and comorbidities were recorded. Descriptive statistics and Binary Logistic regression analyses were calculated for factors associated with use versus non-use of pharmacotherapy.
RESULTS: 187 patients screened positive for ADHD at the walk-in clinic and after detailed assessments, 101 were diagnosed with ADHD. With every one-point increase in Vanderbilt ADHD Parent Rating Scale (VADPRS) severity score, there is 1.2 times [P = 0.002; Exp(B) = 1.281; 99% CI: 1.089-1.494] higher likelihood of getting a pharmacological prescription for ADHD. Combined presentation has 3.8 times [P = 0.015; Exp(B) = 3.808; 99% CI: 1.295-11.198] higher likelihood of getting a pharmacological prescription compared to only hyperactive/impulsive and inattentive presentations. Among the socio-demographic variables, no statistically significant variables were observed, although the odds ratios among all social categories displayed a meaningful trend.
CONCLUSION: Pharmacotherapy for ADHD at initial diagnosis is strongly predicted by the severity of ADHD and other socio-economic variable that may require equal attention in the coming years.